510(k) Report

510(k) · Cleared

Recalled · Class I · 2021

Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker Bands

K992347510(k) TraditionalCleared Oct 8, 199986-day reviewClass II21 CFR 870.1200Recalls 7 (5 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis Corp. · DQO Catheter, Intravascular, Diagnostic

Cleared on Oct 8, 1999 after an 86-day review. The FDA summary names its predicate without a number. 3 of the 9 devices in its family, counting itself, have a Class I recall. 8 later devices descend from it. It has been recalled 7 times, including 5 Class I recalls.

Decided
Oct 8, 1999
Review
86 days
Class
Class II
Product code
DQO
Recalls
7 (5 Class I)
Predicates
0

8 later devices descend from it, 2 citing it directly. 3 of the 9 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2002: 1 descendant cleared2022: 1 descendant cleared2004: 1 descendant cleared, 1 with a Class I recall12014: 1 descendant cleared2010: 1 descendant cleared, 1 with a Class I recall12017: 1 descendant cleared2018: 2 descendants cleared1995200020052010201520202025
  1. This deviceK992347 Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker…Cordis Corp. · 1999
  2. Descendant · cites it directly · 6 of its ownK020316 Cordis Trapease Permanent Vena Cava Filter with the Visease…Cordis Corp. · 2002
  3. Descendant · 2 generations on · 5 of its ownK034050 Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B…Cordis Corporation · 2004 · Recalled (Class I)
  4. Descendant · 3 generations on · 2 of its ownK162875 Sentry IVC filterNovate Medical, Ltd. · 2017
  5. Descendant · 4 generations on · 1 of its ownK173236 Sentry IVC FilterNovate Medical, Ltd. · 2018
  6. Descendant · 3 generations on · 1 of its ownK091077 Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co. · 2010 · Recalled (Class I)

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2002: 12004: 12010: 12014: 12017: 12018: 22022: 1
2002high 2 (2018) · low 0 (2003)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 8 · See all
  • K020316Cordis Trapease Permanent Vena Cava Filter with the Visease Angiographic Vessel Dilator…Cordis Corp. · 2002 · cites it directly6descendants
  • K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable Catheter…Cordis Corporation · 2004 · 2 generations on5descendants
  • K162875Sentry IVC filterNovate Medical, Ltd. · 2017 · 3 generations on2descendants
  • K173236Sentry IVC FilterNovate Medical, Ltd. · 2018 · 4 generations on1descendant
  • K091077Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co. · 2010 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K992347Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker BandsCordis Corp.1999—
+1K020316Cordis Trapease Permanent Vena Cava Filter with the Visease Angiographic…Cordis Corp.2002—
+2K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable…Cordis Corporation2004Class I
+3K162875Sentry IVC filterNovate Medical, Ltd.2017—
+4K173236Sentry IVC FilterNovate Medical, Ltd.2018—
+3K091077Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co.2010Class I

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
200411
201011
201410
201710
201820
202210
FIG. 1 — Lineage of K992347, 1999–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

3 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQO device

  1. #1 K254278 Arterial Pressure Monitoring Set/Trayscore 14.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Cordis 5.2 F Super Torque Plus Angiographic Catheter
Named without a submission number
—
*—Cook Aurous™ Graduated Sizing Catheter
Named without a submission number
—
*—Guidant EVT AngioScale Angiographic Catheter
Named without a submission number
—

What descends from it? (8)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K020316Cordis Trapease Permanent Vena Cava Filter with the Visease Angiographic Vessel Dilator…Cordis Corp.20026
K212977SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbandsCordis Corporation20220

Has anything in its family been recalled? (3 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 21, 2021Class IZ-2432-2021Device DesignCordis has identified that the SUPER TORQUE MB Angiographic Catheter (with Marker Bands) are being used in a manner that may allow entrapment of the catheter between endovascular devices and the vessel wall, which can lead to marker band…
Jul 21, 2021Class IZ-2430-2021Device DesignCordis has identified that the SUPER TORQUE MB Angiographic Catheter (with Marker Bands) are being used in a manner that may allow entrapment of the catheter between endovascular devices and the vessel wall, which can lead to marker band…
Jul 21, 2021Class IZ-2431-2021Device DesignCordis has identified that the SUPER TORQUE MB Angiographic Catheter (with Marker Bands) are being used in a manner that may allow entrapment of the catheter between endovascular devices and the vessel wall, which can lead to marker band…
Jul 21, 2021Class IZ-2428-2021Device DesignCordis has identified that the SUPER TORQUE MB Angiographic Catheter (with Marker Bands) are being used in a manner that may allow entrapment of the catheter between endovascular devices and the vessel wall, which can lead to marker band…
Jul 21, 2021Class IZ-2429-2021Device DesignCordis has identified that the SUPER TORQUE MB Angiographic Catheter (with Marker Bands) are being used in a manner that may allow entrapment of the catheter between endovascular devices and the vessel wall, which can lead to marker band…
Nov 21, 2011Not classifiedZ-0205-2012Error in labelingCordis Corporation is issuing a Correction for their SUPER TORQUE MB Angiographic Catheter after receiving a report of marker bands dislodged during a procedure. Model Numbers 532598A, 532598B, 532598C, 532598D, SRD5724MB and SRD5727MB…
Nov 21, 2011Not classifiedZ-0204-2012Error in labelingCordis Corporation is issuing a Correction for their SUPER TORQUE MB Angiographic Catheter after receiving a report of marker bands dislodged during a procedure. Model Numbers 532598A, 532598B, 532598C, 532598D, SRD5724MB and SRD5727MB…

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable Catheter, Model 466-C220FCordis Corporation · 2004 · 2 generations on · ◆ in the 2004 descendants bar of FIG. 11 Class I recall
  • K091077Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co. · 2010 · 3 generations on · ◆ in the 2010 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K020316 (Cordis Corp., 2002) has gone furthest, with 6 descendants of its own.

How does its category compare?

All DQO devices

DQO Catheter, Intravascular, Diagnostic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQO

2in 2025

2007: 82008: 32009: 82010: 72011: 62012: 152013: 22014: 32015: 102016: 42017: 102018: 102019: 62020: 32021: 12022: 42023: 42024: 42025: 22026 (partial year): 3
2007high 15 (2012) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQO

148in 2024

2007: 106 days median2008: 80 days median2009: 58 days median2010: 137 days median2011: 74 days median2012: 94 days median2014: 109 days median2015: 209 days median2016: 89 days median2017: 176 days median2018: 234 days median2019: 113 days median2020: 30 days median2022: 181 days median2023: 73 days median2024: 148 days median2026 (partial year): 85 days median
2007high 234 (2018) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQO

1in 2023

2007: 142008: 42009: 72010: 112011: 72012: 22013: 12015: 1, 1 Class I2016: 2, 1 Class I2017: 12018: 22019: 712020: 4, 4 Class I2022: 12023: 1, 1 Class I2026 (partial year): 24, 4 Class I
2007high 71 (2019) · low 0 (2014)2026

Class I (11 since 2007) Class II/III not classified

Adverse event reports per year · DQO

656in 2025

2007: 5642008: 7262009: 9332010: 5562011: 6252012: 5322013: 7532014: 6012015: 6282016: 6142017: 8732018: 7772019: 3862020: 3122021: 3382022: 3792023: 3912024: 5112025: 656
2007high 933 (2009) · low 312 (2020)2025

MAUDE reports naming product code DQO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007810614564
20083804726
20098587933
2010713711556
20116747625
201215942532
20132—1753
201431090601
2015102091 (1)628
20164892 (1)614
2017101761873
2018102342777
2019611371386
20203304 (4)312
20211—0338
202241811379
20234731 (1)391
202441480511
20252—0656
202638524 (4)—

What is it indicated for?

The Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker Bands is designed to provide angiographic visualization and linear measurement of the vasculature when combined with the delivery of radiopaque contrast media to selected sites in the vascular system.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K992347: Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker Bands.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K992347

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026